Your browser doesn't support javascript.
loading
INEXAS: A Phase 2 Randomized Trial of On-demand Inhaled Interferon Beta-1a in Severe Asthmatics.
McCrae, Christopher; Olsson, Marita; Gustafson, Per; Malmgren, Anna; Aurell, Malin; Fagerås, Malin; Da Silva, Carla A; Cavallin, Anders; Paraskos, Jonathan; Karlsson, Karin; Wingren, Cecilia; Monk, Phillip; Marsden, Richard; Harrison, Tim.
Afiliação
  • McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Olsson M; Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Gustafson P; Early Biometrics and Statistical Innovation, Data Science and AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Malmgren A; BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden.
  • Aurell M; Early Respiratory & Immunology Projects Department, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Fagerås M; Early Respiratory & Immunology Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Da Silva CA; BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden.
  • Cavallin A; Early Respiratory & Immunology Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Paraskos J; Translational Science and Experimental Medicine, Early Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Karlsson K; Point of Care Diagnostics, Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Wingren C; Translational Science and Experimental Medicine, Early Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Monk P; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Marsden R; Synairgen Research Ltd, Southampton University Hospital, Southampton, UK.
  • Harrison T; Synairgen Research Ltd, Southampton University Hospital, Southampton, UK.
Clin Exp Allergy ; 51(2): 273-283, 2021 02.
Article em En | MEDLINE | ID: mdl-33091192
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções Respiratórias / Asma / Interferon beta-1a Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções Respiratórias / Asma / Interferon beta-1a Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos